baber/WOPTO huggingface dataset:
Patent AU-713739-B2 (AU)
Title: Preparation of polymers of alkenes by suspension polymerization
Inventor: LYNCH JOHN
IPC: C08F4/60
Filed: 1997-02-19
Granted: 1999-12-09
Abstract: Polymers of alkenes are prepared by suspension polymerization in the presence of catalyst systems by a process in which the catalyst systems used are supported catalyst systems obtainable by A) reaction of an inorganic carrier with a metal compound of the general formula I<paragraph lvl="0"><in-line-formula>M1(R1)r(R2)s(R3)t(R4)u  I</in-line-formula>where M1 is an alkali metal, an alkaline earth metal or a metal of main group III or IV of the Periodic Table, R1 is hydrogen, C1-C10-alkyl, C6-C15-aryl, alkylaryl or arylalkyl, each having 1 to 10 carbon atoms in the alkyl radical and 6 to 20 carbon atoms in the aryl radical, R2 to R4 are each hydrogen, halogen, C1-C10-alkyl, C6-C15-aryl, alkylaryl, arylalkyl, alkoxy or dialkylamino, each having 1 to 10 carbon atoms in the alkyl radical and 6 to 20 carbon atoms in the aryl radical, r is an integer from 1 to 4 and s, t and u are integers from 0 to 3, the sum r+s+t+u corresponding to the valency of M1, B) reaction of the material obtained according to A) with a metallocene complex in its metal dihalide form and a compound forming metallocenium ions and C) subsequent reaction with a metal compound of the general formula II M2(R5)o(R6)p(R7)q  IIin which M2 is an alkali metal, an alkaline earth metal or a metal of main group III of the Periodic Table, R5 is hydrogen, C1-C10-alkyl, C6-C15-aryl, alkylaryl or arylalkyl, each having 1 to 10 carbon atoms in the alkyl radical and 6 to 20 carbon atoms in the aryl radical, R6 and R7 are each hydrogen, halogen, C1-C<hi
Patent AU-681021-B2 (AU)
Title: Indole derivative and medicine containing the same
Inventor: YOSHIDA KIYOSHI
IPC: C07D209/12
Filed: 1995-03-29
Granted: 1997-08-14
Abstract: The present invention relates to an indole derivative represented by formula (1) or a salt thereof, and a pharmaceutical containing the derivative or the salt: <CHEM> Äwherein R<1> represents lower alkyl; R<2> represents hydrogen or phenyl which may be substituted by at least one lower alkyl, lower alkoxy or a halogen atom; R<3> represents hydrogen, lower alkyl, lower alkoxy, or phenylalkyloxy which may be substituted by halogen or lower alkyl; R<4> represents hydrogen, lower alkyl or lower alkoxy; R<5> represents hydrogen or lower alkyl; and n represents an integer of 1 to 5Ü. This compound has the effects of both blocking alpha 1-adrenergic receptors and inhibiting testosterone 5 alpha -reductases, and is useful as a remedy and/or a preventive for diseases caused by dihydrotestosterone overproduction, such as prostatic hypertrophy, and diseases accompanying the same, such as urination disorder, male pattern alopecia, acne, and so forth.
Patent AU-720950-B2 (AU)
Title: Automated balloon inflation device
Inventor: NELSON DAVID C
IPC: A63H27/10
Filed: 1997-01-31
Granted: 2000-06-15
Abstract: An automated balloon inflation device which has a supply of pressurized gas, a nozzle for receiving a balloon, and an actuator for sequentially closing a clamp on the balloon and the nozzle and subsequently supplying the pressurized gas to the balloon for the inflation thereof. Furthermore, a key-weight device may be employed for the dual purpose of controlling the supply of pressurized gas to the nozzle and to prevent the inadvertent loss of an inflated balloon which is secured to the key-weight. Additionally, the automated balloon inflation device is constructed so that any consumer may inflate a balloon with pressurized gas. In another embodiment, the automated balloon inflation device employs a connection block with a series of conduits therein to interconnect the pressurized gas supply with the clamping mechanism and the nozzle. This embodiment employs a clamping mechanism which uses a piston attached to a gear wherein the gears rotate clamping jaws onto the nozzle. The present embodiment also provides a door trigger mechanism which only allows gas to flow to the nozzle and clamping mechanism when a door to the device is closed.
Patent AU-775624-B2 (AU)
Title: Method and apparatus for dynamic command extensibility in an intelligent agent
Inventor: ABBOTT AARON
IPC: G06F9/445
Filed: 1999-12-22
Granted: 2004-08-05
Abstract: A system is provided whereby software components acting as servers can be upgraded or installed when new functionality is required without client components which have made requests to these components being made aware of the upgrade initiated by their request. The servers can then respond to requests which would otherwise have caused errors in the client components.
Patent AU-710242-B2 (AU)
Title: Photopheresis treatment of leukocytes
Inventor: MCLAUGHLIN SUSAN N
IPC: A61K41/00
Filed: 1997-03-26
Granted: 1999-09-16
Abstract: A method of treating infections of mononuclear blood cells, other than retroviral infections, is disclosed. A method of modulating the function of monocytes is also disclosed. The method involves the treatment of a patient's blood with a photoactivatable compound followed by ultra violet light-activation of the photoactivatable compound. The blood treated as such is returned to the patient in a process known as extracorporeal photopheresis. Monocyte function is modulated by this treatment.
Patent AU-766188-B2 (AU)
Title: Vascular graft with improved surface flow
Inventor: BRAUKER JAMES H
IPC: A61L27/34
Filed: 2000-01-12
Granted: 2003-10-09
Abstract: An ePTFE vascular graft having a smooth PTFE luminal surface which is substantially non-adhesive to occlusive blood components. Preferably the graft is a longitudinally extruded and expanded ePTFE tube of about 10-30 microns mean fibril length and is provided with a luminal surface covering of an ePTFE film of small mean fibril length (5 microns of less) which provides the smooth luminal PTFE surface. The graft is anticipated to be particularly effective as a small diameter graft (6 mm or smaller). It is anticipated to have utility as a conventional vascular graft, as a cardiovascular patch and as an intraluminal vascular graft and as a covering for stents.
Patent AU-764899-B2 (AU)
Title: Polymerization processes using dilute multi-component feeds
Inventor: PATIL ABHIMANYU ONKAR
IPC: C08G67/02
Filed: 2000-01-14
Granted: 2003-09-04
Abstract: The invention relates to a method of forming carbon monoxide-containing polymers from multi-component syngas feeds and at least one vinyl comonomer. Feeds useful in the practice of the invention comprise ethylene in an amount ranging from about 5 to about 40 mole %, carbon monoxide is an amount ranging from about 1 to about 40 mole %, hydrogen in an amount ranging from about 4 to about 55 mole %, carbon dioxide in an amount ranging from about 3 to about 10 mole %, and methane in an amount ranging from about 4 to about 85 mole %. The feed may also include acetylene in an amount ranging up to about 10 mole %. The feed may contain at least one free radical-polymerizable vinyl comonomer, or a cofeed containing such a comonomer can be used.
Patent AU-739253-B2 (AU)
Title: Device for continuously monitoring the junction of a conveyor belt
Inventor: SCHNELL WOLFGANG
IPC: B65G43/02
Filed: 1999-01-25
Granted: 2001-10-04
Abstract: The present invention relates to a device for continuously monitoring the junction of a conveyor belt which is made of rubber or a rubber-type plastic material and which comprises supports inserted therein for reinforcing the same. In an advantageous embodiment, the device essentially comprises the following constituent members for the junction area: mainly four reference marks, two addresses as well as four detection heads, the heads being located above the carrier surface of the conveyor belt. This invention further relates to other advantageous embodiments of this device.
Patent AU-695769-B2 (AU)
Title: Helicobacter proteins and vaccines
Inventor: KELLEHER DERMOT
IPC: A61P35/00
Filed: 1995-07-03
Granted: 1998-08-20
Abstract: A vaccine includes at least one Helicobacter, especially Helicobacter pylori protein to which immunoreactivity is detected in H. pylori negative individuals. The Helicobacter proteins are preferably less than 30 kDa and the vaccine especially includes 24 to 25 kDa and/or 18 to 19 kDa proteins. The vaccine may include interleukin 12 as an adjuvant.
Patent AU-610041-B2 (AU)
Title: An alignment method, in particular for optical components
Inventor: MOUSSEAUX DANIEL
IPC: G02B6/42
Filed: 1989-01-24
Granted: 1991-05-09
Abstract: An optical fiber (F) and a laser (L) are fixed on the top faces of two bases (EF, EL) which also have two facing vertical faces. A spring (4) presses these two faces against each other so as to create thrust friction. The thrust force is initially moderate in order to enable the relative vertical and transverse positions (GV, GT) of the two bases to be adjusted smoothly, after which the force is increased progressively in order to prevent relative displacement taking place while the two bases are being welded together by means of a YAG laser. The invention is particularly applicable to making optical transmission heads usable in optical fiber telecommuncations systems.
Patent AU-572171-B2 (AU)
Title: Polypeptides
Inventor: ENGELS JOACHIM
IPC: C12N15/31
Filed: 1984-07-26
Granted: 1988-05-05
Abstract: Polypeptides with a carboxamide carboxyl terminus and a methionine residue, which is optionally bound to a bacterial protein, at the amino end can be prepared by genetic engineering synthesis of the corresponding polypeptide with a glycine residue at the C terminus and the enzymatic conversion thereof into the amino group of the required carboxamide moiety. Peptides which have the amino-acid sequence of growth hormone releasing factor, part sequences thereof or modifications of these peptides can easily be obtained in this way. The genetic engineering synthesis is expediently carried out using two gene fragments which are chemically synthesised from single-stranded smaller fragments. The two gene fragments are then linked enzymatically to give the complete gene, incorporated in a suitable vector, amplified there, the peptide is isolated directly or as fusion protein and is converted enzymatically into the required amide.
Patent AU-704247-B2 (AU)
Title: Method for the preparation of (+/-)-calanolide A and intermediates thereof
Inventor: FLAVIN MICHAEL T
IPC: A61P37/04
Filed: 1995-08-02
Granted: 1999-04-15
Abstract: The application describes the conversion of chromene 4 to chromanome 7.
Patent AU-711572-B2 (AU)
Title: Manufacture of cooked cereals
Inventor: GEROMINI OSVALDO
IPC: A23L7/10
Filed: 1995-10-18
Granted: 1999-10-14
Abstract: Issued in Week 9648. First Major Country Equivalent to NO9504206A.   Prodn. of cooked cereals or dry animal feeds comprises preparing a mixt. of water and a dry premix comprising mainly cereal flour or semolina; cooking the mixt.; and extruding it through a die by means of a gear pump. Also claimed is appts. for carrying out the above process, comprising a mixing and/or cooking device, a gear pump and an extrusion die.
Patent AU-668555-B2 (AU)
Title: Furniture with a tubular underframe
Inventor: FICH PREBEN BO
IPC: F16B12/40
Filed: 1993-04-02
Granted: 1996-05-09
Abstract: PCT No. PCT/DK93/00123 Sec. 371 Date Sep. 21, 1994 Sec. 102(e) Date Sep. 21, 1994 PCT Filed Apr. 2, 1993 PCT Pub. No. WO93/19639 PCT Pub. Date Oct. 14, 1993A piece of furniture (1) including an upper part (2) and a lower part, the lower part having rails (8) and legs (3, 4, 5, 6, 7,) made of tubes. The legs have an upper tubular end with a tubular connecting piece (9) fixedly connected with and forming an angle with the leg. An assembly device (10, 11, 12, 13, 14) is provided which has two connecting members (30, 31) each having at least two legs (21, 22), one leg of each member being inserted in an end of the connecting piece (9) and at least one other leg of each member being inserted in a tubular end of a rail (8), wherein one of the legs of the assembly device forms an angle with at least one other leg of the assembly device. The connecting members are pressed against an inner side of the tubular rails and connecting pieces by screws passing through holes in the legs of the connecting members, and the legs of the connecting members have a size and shape which substantially fills up an interior of the tubular ends. The screws are accessible through an aperture in a wall of each of the tubular ends of the rails and connecting pieces.
Patent AU-617235-B2 (AU)
Title: Control of fungal diseases in the production of mushrooms
Inventor: ARMSTRONG GALE L
IPC: A01N35/02
Filed: 1990-01-16
Granted: 1991-11-21
Abstract: A method of controlling toxic fungal diseases in mushrooms is provided which comprises adding an effective fungal-disease-inhibiting amount of a compound of the formula <CHEM> to a substrate in which mushrooms are growing or are to be grown, wherein R represents -CH2OH or -CHO; n is an integer from 0 to 3; and each R<1> independently represents halogen, OH, NH2, or an organic substituent containing from 1 to 10 carbon atoms and from 0 to 5 heteroatoms, wherein the total number of carbon and heteroatoms in all R<1> substituents is no more than 15.
Patent AU-772684-B2 (AU)
Title: Cosmetic compositions containing optical brighteners
Inventor: COHEN ISAAC D
IPC: A61K8/00
Filed: 2000-05-23
Granted: 2004-05-06
Abstract: The invention relates to cosmetic composition comprising a fluorescent-effective amount of at least one fluorescent brightener, in combination with a cosmetically acceptable vehicle. The compositions of the invention can be used as color cosmetics and skin treatment products, to replenish the skin's natural fluorescent glow.
Patent AU-635918-B2 (AU)
Title: Bone replacement part made of glass ionomer cement
IPC: C04B28/28
Filed: 1990-03-06
Granted: 1993-04-08
Abstract: Bone prostheses made of glass ionomer cement are superior to those made of ceramics, especially because they are simple to produce and can be shaped easily using conventional grinding and milling tools. The prosthesis part required in each case can be shaped by the surgeon during the operation from freshly mixed glass ionomer cement, or an industrially prefabricated shaped element, which approximates to the ideal shape of the bone part to be replaced, can be adapted to the given anatomical conditions.
Patent AU-765105-B2 (AU)
Title: Herpes virus vectors for dendritic cells
Inventor: COFFIN ROBERT STUART
IPC: A61K39/00
Filed: 1999-08-02
Granted: 2003-09-11
Abstract: An attenuated herpes virus capable of efficiently infecting a dendritic cell without preventing antigen processing occurring within the infected cell. The attenuated herpes virus and dendritic cells infected with the virus are useful immunotherapeutic methods of treating disease.
Patent AU-594657-B2 (AU)
Title: Substituted Dibenz(c,e) azepine derivatives
Inventor: BRUDERER HANS
IPC: C07D223/18
Filed: 1986-01-09
Granted: 1990-03-15
Abstract: The invention is concerned with novel heterocyclic compounds of the formula    <IMAGE>  I  wherein R is C1-12-alkyl, C3-12-alkenyl, C3-12-alkynyl or C3-8-cycloalkyl and X signifies oxygen or sulfur, and none of the possible multiple bonds of R is present in the  alpha -position of X, and their acid addition salts, processes for their manufacture, pest control compositions which contain these compounds as the active substance as well as the use of such compounds or compositions for the control of pests. Moreover, the invention is concerned with starting materials used for the preparation of such compounds.
Patent AU-640646-B2 (AU)
Title: Information recording system, and recording device and record carrier for use in such an information recording system
IPC: G11B7/013
Filed: 1990-05-07
Granted: 1993-09-02
Abstract: By means of a preformed track modulation (Fig. 1c, Fig. 1d) an auxiliary signal is recorded on a record carrier (1) of an inscribable type in a servo track (4) intended for information recording. The auxiliary signal comprises address codes (AC) and auxiliary codes (HC) which can be distinguished from each other. The address codes specify the address of the track portion in which said codes are recorded, and the auxiliary codes provide additional information about the record carrier, such as references to a track portion having a specific address code. A recording device comprises means (82, 86, 88, 90, 92) for reading the auxiliary signal recorded by means of the track modulation and means (93) for separately detecting the presence of address codes (AC) and the presence of auxiliary codes (HC) in the auxiliary signal.
Patent AU-628575-B2 (AU)
Title: Layered two-ply tissue process and product
Inventor: ALLEN PETER JOHN
IPC: D21F9/02
Filed: 1990-05-30
Granted: 1992-09-17
Abstract: A soft tissue product is made by forming a layered web with a crescent former, wherein the layer of the web (15) which is in contact with the felt (3) contains a substantial amount of short fibers, such as eucalyptus fibers. The tissue web is dried such that the opposite side of the web is pressed against the dryer (20) surface and creped. The resulting tissue web is plied together with another tissue web such that the layers (15) containing the substantial amount of short fibers become the outwardly facing layers of the two-ply tissue product.
Patent AU-676703-B2 (AU)
Title: Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives
Inventor: JANSSENS FRANS EDUARD
IPC: A61K31/55
Filed: 1993-11-25
Granted: 1997-03-20
Abstract: PCT No. PCT/EP93/03322 Sec. 371 Date May 8, 1995 Sec. 102(e) Date May 8, 1995 PCT Filed Nov. 25, 1993 PCT Pub. No. WO94/13681 PCT Pub. Date Jun. 23, 1994Antiallergic triazolo(pyrrolo, thieno or furano)azepines of formula    <IMAGE>  (I)  the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; -E-G- is a bivalent radical of formula -X-C(R1)=CH- (a-1); or -CH=C(R2)-X- (a-2); X represents O, S or NR3; R3 represents hydrogen, C1-6alkyl or C1-4alkylcarbonyl; -B=D- is a bivalent radical of formula -C(R4)=N- (b-1); or -N=C(R5)- (b-2); L represents hydrogen; C1-6alkyl; substituted C1-6alkyl; C3-6alkenyl; C3-6alkenyl substituted with aryl; or, L represents a radical of formula -Alk-Y-Het1 (c-1), -Alk-NH-CO-Het2 (c-2) or -Alk-Het3 (c-3). Compositions comprising said compounds, processes of preparing the same and intermediates in the preparation thereof.
Patent AU-636148-B2 (AU)
Title: Human leukocyte elastase inhibitors
IPC: C12N15/15
Filed: 1990-06-05
Granted: 1993-04-22
Abstract: Polypeptides, in particular the polypeptide of formula I: Ala-Gln-Glu-Pro-Val-Lys-Gly-Pro-Val-Ser-Thr-Lys-Pro-Gly-Ser-Cys-Pro-Il e-Ile-Leu- Ile-Arg-Cys-Ala-Met-Leu-Asn-Pro-Pro-Asn-Arg-Cys-Leu-Lys-Asp-Thr-Asp-Cy s-Pro-Gly- Ile-Lys-Lys-Cys-Cys-Glu-Gly-Ser-Cys-Gly-Met-Ala-Cys-Phe-Val-Pro-Gln and analogues thereof which possess inhibitory activity against human leukocyte elastase. The polypeptides may be obtained by expression using plasmidic expression systems in hosts such as E. Coli and yeast, the polypeptide of formula I being also obtainable from psoriatic plaques.
Patent AU-779486-B2 (AU)
Title: Neurotrophic factor receptor
Inventor: MASURE STEFAN LEO JOZEF
IPC: A01K67/027
Filed: 2000-05-26
Granted: 2005-01-27
Abstract: There is disclosed a novel mammalian receptor protein designated GFRalpha-4 and the nucleic acid sequence encoding therefore; an isolated and purified GFR alpha-4 receptor polypeptide comprising SEQ ID NO: 9. Also provided is an expression vector comprising the nucleic acid sequence and host cells transformed or transfected with the vector. Host cells expressing the receptor may be used to identify agonists or antagonists in relation to the receptor.
Patent AU-731781-B2 (AU)
Title: Polarisation asymmetric active optical waveguide, method of its production, and its uses
Inventor: KRISTENSEN MARTIN
IPC: H01S3/08
Filed: 1998-02-13
Granted: 2001-04-05
Abstract: A method of producing an active optical waveguide having asymmetric polarization, said method comprising the steps of (a) providing an active optical waveguide (10) comprising: (i) a transverse refractive index profile (21) comprising a guiding region (11), an intermediate region (13), and a non-guiding region (12); (ii) a transverse photorefractive dopant profile (31) comprising a constant or graded photorefractive dopant concentration within at least one of the guiding, non-guiding and intermediate regions, except that the photorefractive dopant is not located solely in the guiding region; and (iii) exhibiting in said guiding region, intermediate region, or both, light guiding modes having different polarizations; and (b) exposing at least a part (10a, 10b) of the active optical waveguide to an effective transverse illumination of light (20) reacting with the photorefractive dopant and modifying said transverse refractive index profile; said part of the active optical waveguide being exposed to a fluence selectively suppressing the propagation of the light guiding modes having different polarizations so that the propagation of one mode is less suppressed than the propagation of the other mode(s). Such an active optical waveguide, single polarization mode optical waveguide lasers and multi-wavelength single polarization mode optical waveguide lasers comprising such an active optical waveguide, methods of their production, and their uses in telecommunications, in spectroscopy, in sensors and in absolute calibrated laser light sources.
Patent AU-776019-B2 (AU)
Title: Medicated chewing gum delivery system for nicotine
Inventor: CHERUKURI SUBRAMAN R
IPC: A61K9/00
Filed: 1999-09-03
Granted: 2004-08-26
Abstract: A chewing gum delivery system has nicotine, gum base and a buffer system with an improved release rate for the nicotine. The resulting delivery system advantageously provides a convenient, reliable, practical, and relatively painless system for delivering an active. The delivery system is capable of delivering initial and second doses of a craving reduction active or other actives (e.g., nicotine), the combination of which rapidly reduces cravings, or provides some other pharmacological effect, and provides the pharmacological effect or protection from such cravings over a prolonged period of time beyond the initial dose. Notably, the delivery system is capable of rapidly achieving a pharmacologically effective concentration of the active (e.g., nicotine) in the bloodstream (e.g., within 5 minutes, or more desirably within 3 minutes, or in some cases, within 1-2 minutes) and is also capable of keeping the concentration of the active in the bloodstream at or near the pharmacologically effective concentration for at least 20 minutes after chewing of the delivery system begins, or more desirably about 30 minutes to about 50 minutes after chewing begins.
Patent AU-776915-B2 (AU)
Title: Method for disinfecting the air
Inventor: SCHUR JORG PETER
IPC: A61L9/01
Filed: 2000-07-07
Granted: 2004-09-23
Abstract: The invention relates to a method for disinfecting the air, comprising the distribution or atomization of a special antimicrobial composition. The invention also relates to antimicrobial compositions and the use thereof in order to disinfect the air.
Patent AU-645514-B2 (AU)
Title: Uses of interleukin-4 and method for purifying it
Inventor: BONNEM ERIC
IPC: C07K14/54
Filed: 1990-07-26
Granted: 1994-01-20
Abstract: A method is provided for purifying interleukin-4 which involves the successive steps of chromatography on a metal chelating agarose gel, chromatography on a cation exchanger, concentration on a stirred cell membrane and size exclusion chromatography.